Private Banking|Professional Solutions|Investment Management|Investment Banking|About us
Login
Van Lanschot Kempen Logo
  • Solutions
  • Sectors
  • Careers
Login
Oct 2014
probiodrug
Sole Global Coordinator & Sole Bookrunner
€ 23 million
Initial Public Offering

Probiodrug

Probiodrug is a biopharmaceutical company dedicated to the research and development of novel therapeutic solutions to treat people with Alzheimer’s Disease.

  • Probiodrug floated on Euronext Amsterdam with an initial market capitalisation of €102m
  • Proceeds of the offering will be used to execute the phase 2a study of its lead product in Alzheimer’s patients
  • Efforts resulted in an order book mainly made up of long-term specialist investors, despite turbulent markets
     

Fully focused on your future

Private Banking

  • Offices
  • Entrepreneurs
  • Healthcare
  • Executives
  • Business professionals
  • Wealth management
  • Conditions
  • Private Banking - Belgium
  • Private Banking - Switzerland

Professional Solutions


Investment Management


Investment Banking



© Van Lanschot Kempen NV 2023
About us
Security and fraud awareness
Privacy & cookies
Disclaimer